Investor Notice: March 8th Deadline for Investors who Lost over $100,000 in Talis Biomedical Corporation shares announced by Shareholders Foundation
SAN DIEGO, Feb. 22, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline is coming up on March 8, 2022, in the lawsuit that was filed for certain investors in (NASDAQ: TLIS) shares.
Investors who have losses of over
On January 7, 2021, a lawsuit was filed against Talis Biomedical Corporation over alleged Securities Laws Violations. The plaintiff alleges that the defendants failed to disclose to investors that the comparator assay in the primary study lacked sufficient sensitivity to support Talis's EUA application for Talis One COVID-19 test, that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Talis One COVID-19 test, that, as a result, the Company's commercialization timeline would be significantly delayed, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-notice-march-8th-deadline-for-investors-who-lost-over-100-000-in-talis-biomedical-corporation-shares-announced-by-shareholders-foundation-301487190.html
SOURCE Shareholders Foundation, Inc.
